- Report
- May 2026
- 379 Pages
Global
From €5202EUR$5,850USD£4,500GBP
- Report
- January 2026
- 180 Pages
Global
From €4002EUR$4,500USD£3,462GBP
- Report
- January 2026
- 185 Pages
Global
From €4002EUR$4,500USD£3,462GBP
- Report
- June 2025
- 150 Pages
Global
From €2400EUR$2,699USD£2,076GBP
- Report
- June 2025
- 200 Pages
Global
From €2480EUR$2,789USD£2,146GBP
- Report
- March 2026
- 197 Pages
Global
From €4442EUR$4,995USD£3,843GBP
- Report
- August 2025
- 150 Pages
Global
From €4313EUR$4,850USD£3,731GBP
- Report
- July 2025
- 150 Pages
Global
From €4313EUR$4,850USD£3,731GBP
- Report
- February 2026
- 160 Pages
Global
From €2953EUR$3,320USD£2,554GBP
€3691EUR$4,150USD£3,193GBP
- Report
- February 2026
- 200 Pages
Global
From €4442EUR$4,995USD£3,843GBP
- Report
- February 2026
- 191 Pages
Global
From €4442EUR$4,995USD£3,843GBP
- Report
- May 2025
- 134 Pages
Global
From €16003EUR$17,995USD£13,843GBP
- Report
- March 2026
- 177 Pages
Global
From €16003EUR$17,995USD£13,843GBP
- Report
- August 2025
- 98 Pages
Global
From €4313EUR$4,850USD£3,731GBP
- Report
- May 2026
- 50 Pages
Global
From €2357EUR$2,650USD£2,039GBP
- Report
- May 2026
- 50 Pages
Global
From €2357EUR$2,650USD£2,039GBP
- Report
- May 2026
- 50 Pages
Global
From €2357EUR$2,650USD£2,039GBP
- Report
- May 2026
- 50 Pages
Global
From €2357EUR$2,650USD£2,039GBP
- Report
- May 2026
- 50 Pages
Global
From €2357EUR$2,650USD£2,039GBP
- Report
- January 2026
Global
From €6670EUR$7,500USD£5,770GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more